SEC Form 4 · accession 0001636178-26-000029
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Edgemond
Officer — CFO AND TREASURER
Period of report
Jun 22, 2026
Accepted (ET)
Jun 23, 2026 · 4:34 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 22, 2026 | M | 8,750 | $146.03 | A | 27,626 | D | |
| Common StockF2 | Jun 22, 2026 | S | 164 | $534.0595 | D | 27,462 | D | |
| Common StockF3 | Jun 22, 2026 | S | 865 | $534.9849 | D | 26,597 | D | |
| Common StockF4 | Jun 22, 2026 | S | 1,091 | $536.0466 | D | 25,506 | D | |
| Common StockF5 | Jun 22, 2026 | S | 840 | $537.1829 | D | 24,666 | D | |
| Common StockF6 | Jun 22, 2026 | S | 2,266 | $538.234 | D | 22,400 | D | |
| Common StockF7 | Jun 22, 2026 | S | 1,994 | $539.1301 | D | 20,406 | D | |
| Common StockF8 | Jun 22, 2026 | S | 280 | $539.8261 | D | 20,126 | D | |
| Common Stock | Jun 22, 2026 | S | 1,250 | $541.25 | D | 18,876 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $146.03 | Jun 22, 2026 | M | 8,750 | D | Mar 15, 2020 | Mar 15, 2027 | Common Stock | 8,750 | 0 | D |
Explanation of responses
- F1This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.
- F2This transaction was executed in multiple trades at prices ranging from $533.57 to $534.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $534.57 to $535.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $535.64 to $536.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $536.65 to $537.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $537.67 to $538.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $538.67 to $539.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $539.68 to $539.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.